Luo N - Search Results

1

Relative dose intensity and therapy efficacy in different breast cancer molecular subtypes: a retrospective study of early stage breast cancer patients treated with neoadjuvant chemotherapy.

Yuan JQ, Wang SM, Tang LL, Mao J, Wu YH, Hai J, Luo SY, Ou HY, Guo L, Liao LQ, Huang J, Li Y, Xiao Z, Zhang KJ, Luo N, Chen FY. Yuan JQ, et al. Among authors: luo n, luo sy. Breast Cancer Res Treat. 2015 Jun;151(2):405-13. doi: 10.1007/s10549-015-3418-z. Epub 2015 May 9. Breast Cancer Res Treat. 2015. PMID: 25956059

2

The application of aptamer 5TR1 in triple negative breast cancer target therapy.

Luo S, Wang S, Luo N, Chen F, Hu C, Zhang K. Luo S, et al. Among authors: luo n. J Cell Biochem. 2018 Jan;119(1):896-908. doi: 10.1002/jcb.26254. Epub 2017 Aug 17. J Cell Biochem. 2018. PMID: 28671278

3

MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.

Chen F, Luo N, Hu Y, Li X, Zhang K. Chen F, et al. Among authors: luo n. Cell Physiol Biochem. 2018;47(5):2147-2158. doi: 10.1159/000491526. Epub 2018 Jul 5. Cell Physiol Biochem. 2018. PMID: 29975921 Free article.

4

ERRα activates SHMT2 transcription to enhance the resistance of breast cancer to lapatinib via modulating the mitochondrial metabolic adaption.

Li X, Zhang K, Hu Y, Luo N. Li X, et al. Among authors: luo n. Biosci Rep. 2020 Jan 31;40(1):BSR20192465. doi: 10.1042/BSR20192465. Biosci Rep. 2020. PMID: 31894856 Free PMC article.

5

ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.

Luo N, Zhang K, Li X, Hu Y. Luo N, et al. J Cell Biochem. 2020 Oct;121(10):4176-4187. doi: 10.1002/jcb.29572. Epub 2020 Jan 10. J Cell Biochem. 2020. PMID: 31922280

6

miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis.

Zhang KJ, Hu Y, Luo N, Li X, Chen FY, Yuan JQ, Guo L. Zhang KJ, et al. Among authors: luo n. Int J Oncol. 2020 May;56(5):1240-1251. doi: 10.3892/ijo.2020.4995. Epub 2020 Feb 20. Int J Oncol. 2020. PMID: 32319565

7

Circular RNA circHIPK3 promotes breast cancer progression via sponging MiR-326.

Luo N, Liu S, Li X, Hu Y, Zhang K. Luo N, et al. Cell Cycle. 2021 Jul;20(13):1320-1333. doi: 10.1080/15384101.2021.1939476. Epub 2021 Jun 21. Cell Cycle. 2021. PMID: 34152928 Free PMC article.

8

L-norvaline affects the proliferation of breast cancer cells based on the microbiome and metabolome analysis.

Zhu Q, Zai H, Zhang K, Zhang X, Luo N, Li X, Hu Y, Wu Y. Zhu Q, et al. Among authors: luo n. J Appl Microbiol. 2022 Aug;133(2):1014-1026. doi: 10.1111/jam.15620. Epub 2022 May 25. J Appl Microbiol. 2022. PMID: 35543360

9

YTHDF2 Regulates Cell Growth and Cycle by Facilitating KDM1A mRNA Stability.

Li X, Zhang K, Hu Y, Luo N. Li X, et al. Among authors: luo n. Am J Pathol. 2023 Apr;193(4):442-455. doi: 10.1016/j.ajpath.2022.12.010. Epub 2023 Jan 18. Am J Pathol. 2023. PMID: 36681189 Free article.

10

A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis.

Hu Y, He Y, Luo N, Li X, Guo L, Zhang K. Hu Y, et al. Among authors: luo n. Cancer Biol Ther. 2023 Dec 31;24(1):2235768. doi: 10.1080/15384047.2023.2235768. Cancer Biol Ther. 2023. PMID: 37548553 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,705 results

Search Page

Filters